When we first talked to CEO Ramesh Sundararajan with Atlanta-based GenAI Healthcare in 2024, the team was a startup to watch at the Atlanta Startup Awards ceremony. After rolling out its NexCura platform for wellness insights, the team is now getting ready to be in market with a wearable health device that translates real-time biometrics and biomarkers.
Its product, NxRing, is now available for pre-orders. As its first product gets into the hands of its first customers, we caught up with Sundararajan and his team to learn about the process of rolling out a physical product as an AI company and what’s next for the growing Atlanta startup.
Read through our Q&A here:
Question: Walk us through the process of building out NexCura and NxRing. Were there any challenges in building / figuring out the manufacturing?
Answer: For manufacturing, we wanted to ensure the highest quality hardware for our customers, it was difficult to find a unit that would realize our vision of the ring. We landed in Japan.
In building NexCura, our primary goal was always to provide a platform that would enable individuals to take ownership of their health and to stop reacting to health concerns, but preventing them in the first place.
We had created an app that would allow individuals to do exactly that, input their blood tests and symptoms and receive a detailed analysis of their health, all from sitting at home.
Initially, we had stopped at the software, and we welcomed a user to use any wearable device of their choosing to integrate their diagnostic data with biometrics measured by the device. However we noticed limitations in others’ devices that were hindering the level of precision we aimed to provide our users about their health profile.
That’s when we decided we needed to create our own wearable. One that seamlessly integrates with our algorithm, to provide an accurate picture of each individual’s health, that we ourselves would be satisfied with using.
Through extensive research and the recruitment of our engineers, we had assembled our vision for theNxRing and we needed a manufacturing unit. Naturally, for assembly the first place that comes to mind is China and we started there. But still, we weren’t satisfied with the quality of the product that we would be sending out to our users. After months of testing prototypes, we landed on a unit in Japan, and we knew from the first prototype this was it. Our vision for the NxRing was realized and was nothing short of the quality assurance that we had expected.
Question: Do you see products like Apple Watch and Oura ring as competitors? How do you differentiate from such large players in the market?
Answer: We don’t see them as competitors, because fundamentally, NexCura is not a hardware company, we are a health technology company, and the hardware is simply a medium to access a plethora of health insights on our app using our proprietary algorithm.
Where OURA and the Apple Watch also aim to provide the most benefit to the consumer market, NexCura is heading to the underrepresented enterprise wellness and caregivers market. We aim to be used by corporations for wellness programs, and by hospitals, creating specialized interfaces for patients.
Question: Are the rings manufactured in the US? If not, have tariffs impacted anything about your business?
Answer: The rings are manufactured in Japan, which has caused difficulties with regard to tariffs, however these losses could have been worse, say, we manufactured in China. In the future, we plan to bring manufacturing to the US, providing jobs in our local market and of course avoiding these tariffs.
Question: Have you taken on any outside capital?
Answer: We’ve raised $2M of pre-seed funding.
Question: Is this HSA/FSA eligible?
Answer: We are currently in the process of getting HSA/HFA approval. We are projected to be approved by the start of Q4 2026.
Question: Can you give a general range of what pricing looks like?
Answer: $249.99 for the ring.
$49.99 for the subscription annually
Question: To date, is there a specific demographic of people who have been early adopters of the NexCura AI platform?
Answer: Leveraging on our connections in the Atlanta-metro area and participation in conferences such as the ITServe Alliance, the Indian-American population have been early-adopters of NexCura technology.
Given NexCura’s unique caregiving feature, which allows caregivers to view their beloved ones’ health metrics across the world, this has been a huge selling point for this demographic. We plan to further target the diaspora populations of other groups as part of our consumer strategy.
Question: Tell us more about the team you’ve assembled. How many people are on payroll and please describe their roles.
Answer: We have a total of 25 employees that work across technical development, engineering, sales, operations and marketing.